Un equipo del CNIC descubre un nuevo factor de riesgo cardiovascular e identifica un fármaco capaz de reducir sus efectos
Dos estudios realizados en el CNIC aportan información relevante sobre un nuevo factor de riesgo cardiovascular, la hematopoyesis clonal, y su tratamiento con un fármaco ancestral, la colchicina A los ya conocidos factores de riesgo cardiovascular como la presión arterial alta, el colesterol elevado, la diabetes, la obesidad y el sobrepeso, el tabaquismo y la inactividad física, […]
Jose Javier Fuster delivers plenary lecture at GTH 2024
Jose Javier Fuster, coordinator of atheroclonal, delivered a plenary lecture at the 68th Annual Meeting of the Society of Thrombosis and Haemostasis Research celebrated in Vienna, Austria, from February 27th to March 1st. The Society of Thrombosis and Haemostasis Research was founded in 1982. Since then, GTH has held a conference in Germany, Austria or […]
CNIC hosts Cardioguía – a dissemination event about cardiovascular risk factors
Atheroclonal´s CNIC team, together with other CNIC researchers, has participated in the organization and presentation of Cardioguía, a dissemination event focused on educating the public about risk factors of cardiovascular disease and its prevention, celebrated last week at CNIC. Cardioguía hosted talks by Atheroclonal members Jose Javier Fuster and Benedetta Izzi, talking about clonal hematopoiesis […]
ICREC Group
ICREC group focuses on both basic and clinical research approaches to heart failure and cardiac regeneration. They work on the identification of prognostic factors and biomarkers of heart failure progression. Additionally, they have a translational focus, working also with stem cells and tissue engineering to develop biocompatible patches and polymers to regenerate heart tissue.
BBGLab
The Biomedical Genomics (BBGLab) research group is focused on the study of cancer and somatic tissues in general from a genomics perspective. They have made major contributions in the identification of cancer genes and cancer driver mutations across tumor types; in understanding the mutational processes that lead to the accumulation of mutations in tumors and […]
Atheroclonal Consortium
The Hematovascular Pathophysiology Laboratory is focused on evaluating new mechanisms that link clonal hematopoiesis to cardiovascular and metabolic disorders, with an especial interest in context of aging. Their research combines human studies, both cross-sectional and longitudinal, to elucidate the associations between CH and cardiovascular disease, and experimental studies to provide causal evidence and mechanisms of […]
